Cabergoline is a prescription drug that lowers prolactin, the hormone that climbs after orgasm and keeps you in the refractory period. Medically it treats prolactinomas and other causes of high prolactin. Outside the clinic, men take it for one of two reasons: to shorten or flatten the refractory period and get more out of sex, or to control prolactin while running 19-nor anabolic steroids like nandrolone and trenbolone, which push prolactin up and cause libido crashes and a progesterone-driven form of gyno.
The sexual-enhancement use is largely built on anecdote plus a couple of small studies in healthy men, and it is genuinely hit or miss. The steroid-support use is the more established one. Either way, this is not a casual supplement: it is a potent, long-acting dopamine drug with a real side effect profile, and the dose that helps and the dose that causes problems are not far apart.
Deep-dive
Prolactin secretion is unusual among pituitary hormones because it is controlled by inhibition rather than stimulation. Dopamine, released from the hypothalamus, constantly tells the lactotroph cells of the pituitary to keep prolactin low. Cabergoline is a long-acting dopamine D2 receptor agonist, so it sits on those same receptors and mimics dopamine, clamping prolactin production down hard. It has high affinity for D2 and relatively low affinity for D1, adrenergic, and serotonin receptors, which is part of why it is better tolerated than older agonists like bromocriptine.
The half-life is long, around 63 to 69 hours, which is why it is dosed once or twice weekly rather than daily. A single dose suppresses prolactin for days. This is convenient but also the source of much of its risk: if you take too much, you cannot simply stop and feel normal tomorrow.
Why prolactin matters for sex. During the normal male sexual response, prolactin surges after orgasm and stays elevated for roughly an hour. Continuous hormone measurement during orgasm in men and women established this surge, and it is thought to contribute to the refractory period, the window where further arousal and erection are harder. Men who report very short or absent refractory periods may not get the same post-orgasm prolactin spike. The logic of using cabergoline recreationally is to blunt that spike. The logic of using it medically is that chronically high prolactin suppresses GnRH, which drops LH and testosterone, producing low libido, erectile dysfunction, and in men sometimes gynecomastia or galactorrhea.
Evidence in healthy men. The most cited study is Krüger and colleagues, 2003, which manipulated prolactin in healthy men and found that lowering it improved aspects of sexual drive and function and changed the perception of the refractory period. This is a small study and the foundation for most of the recreational claims. It is suggestive, not definitive. The honest summary is that the data in men who already have normal prolactin is thin, and community reports are split: some men describe a dramatically shorter refractory period and stronger orgasms, others feel nothing or feel flat and unmotivated.
Evidence in men with a clinical problem. This is where cabergoline is on solid ground. In a 4-month randomized, placebo-controlled trial in 50 men with psychogenic erectile dysfunction, cabergoline normalized hormone levels in most cases and significantly improved erectile function, sexual desire, orgasmic function, and both partners' satisfaction. A 6-month open study using nocturnal penile tumescence monitoring found cabergoline restored sexual potency in hyperprolactinemic men. A retrospective analysis of 131 men treated for orgasmic disorder with 0.5 mg twice weekly found about two-thirds reported subjective improvement in orgasm and a third reported no change. The pattern across the clinical literature is consistent: if high prolactin is the actual cause of your problem, fixing it works well. If it isn't, the picture is much less reliable.
Women. Women's sexual response is not just "the same with lower numbers," and cabergoline makes that obvious. In hyperprolactinemic women, prolactin excess is associated with sexual dysfunction, and cabergoline treatment improves sexual functioning across all domains, the same direction as in men. But prolactin is not simply a brake to be removed. A controlled study in young women found that when cabergoline pushed prolactin below the normal range, sexual functioning and mood got worse, not better, and the effect tracked the low prolactin rather than the drug itself. So for women the target is normal prolactin, not minimal prolactin, and overshooting is counterproductive. There is also a vitamin D interaction worth knowing: in reproductive-age hyperprolactinemic women, cabergoline's benefits on sexual function and depressive symptoms were strongest in those with sufficient vitamin D and weakest in those who were deficient, so correcting vitamin D first makes the drug work better. For women without a clinical prolactin problem, there is essentially no good reason and no supporting evidence to use cabergoline for sexual enhancement, and the hypoprolactinaemia data suggests it could backfire.
The 19-nor steroid use case. Nandrolone and trenbolone have progestogenic activity that raises prolactin. Elevated prolactin on cycle drives low libido, erectile dysfunction, anorgasmia, water retention, and a progesterone-mediated form of gynecomastia that aromatase inhibitors do not fully address. Cabergoline restores dopamine's inhibitory signal at the pituitary and brings prolactin back down, which is why it is a common ancillary for men running these compounds. Worth being precise here: cabergoline does not build muscle and does not directly raise testosterone, it just removes the prolactin-driven problems that make a 19-nor cycle miserable. Whether you need it at all depends on the compound and your individual sensitivity, many people run nandrolone without ever needing it. Anabolic steroids, nandrolone, and trenbolone don't have pages yet, flag these.
Impulse control is the underrated risk. Because cabergoline acts on the same D2 reward pathways that drive motivation, it can produce impulse control disorders: compulsive gambling, compulsive shopping, binge eating, and hypersexuality. This is well documented in the clinical literature, including a cross-sectional multicenter study in prolactinoma patients and the FDA prescribing information, which explicitly warns about intense uncontrollable urges. It can be insidious because the person experiencing it often does not connect the behavior to the drug, and it is the people around them who notice first. Mood changes, anxiety, and depression are also reported, and rare cases of mania and psychosis exist. These are not dose-trivial effects and they are a real reason to keep the dose as low as possible and to tell someone close to you that you are taking it.
Mechanistic caveats. Cabergoline is an ergot derivative, and ergot dopamine agonists are the class associated with fibrotic valvular heart disease through 5-HT2B receptor activation on heart valves. The valve risk is dose and duration dependent and has mostly been seen in Parkinson's disease patients on very high cumulative doses, far above what is used for prolactin. At prolactin-level doses the evidence does not show clinically significant valve disease, but the mechanism does not disappear at low doses, it just becomes much less likely, which is why baseline and periodic echocardiograms are still standard. The recreational and bodybuilding doses sit in the same low range as medical hyperprolactinemia treatment, so the same reasoning applies: low risk, not no risk, and worth monitoring if you use it for years.
Dosage:
- This is a once or twice weekly drug, not daily. The half-life is long, around 63 to 69 hours, so a single dose lasts for days. Daily dosing is a mistake and an easy way to overshoot
- Clinical hyperprolactinemia starts at 0.25 mg twice weekly and titrates up slowly, every 4 weeks, based on prolactin bloodwork. The maximum standard medical dose is 1 mg twice weekly. There is no reason for non-clinical use to ever exceed the low end of this range
- For controlling prolactin on a 19-nor steroid cycle, the common approach is 0.25 mg once or twice weekly, started in response to symptoms or a high prolactin reading rather than run blindly from day one. Many people on nandrolone never need it, sensitivity varies a lot
- For recreational refractory-period use, people typically take a single small dose, often 0.25 mg or less, several hours to a day before. More frequent or higher dosing is where impulse control problems, low mood, and the flat "anhedonic" feeling show up
- Titrate by symptoms and bloodwork, not by feel. Prolactin can be driven below the normal range easily, and in both men and women that overshoot makes mood and sexual function worse, not better. The target is normal prolactin, not zero
- Take with or without food. If nausea is an issue, taking it with food and at night helps
- Give any dose change at least 4 weeks before judging it. Because the drug is long-acting, levels and effects take time to settle
- Do not stack with other ergot derivatives. Be cautious combining with blood pressure medication, the hypotensive effects can add up. Dopamine antagonists like antipsychotics and metoclopramide will blunt or cancel its effect
Here's what you can expect:
The prolactin drop itself is fast, often within a day or two of a dose, and you can confirm it on bloodwork. What you actually feel is more variable. In the clinical context, where high prolactin is the real problem, men generally notice libido, erections, and orgasm improving over a few weeks as testosterone recovers. For recreational refractory-period use the response is genuinely split: some men report a clearly shorter refractory period, more intense orgasms, and a feeling of sexual release, while others notice little or feel mentally flat, unmotivated, or low. On a steroid cycle, if prolactin was driving your symptoms, the libido crash and any progesterone-related gyno pressure should ease within a couple of weeks.
The side effects that show up early are nausea, dizziness, headache, and lightheadedness on standing. The ones that show up later and matter more are the psychological ones: changes in mood, and the impulse control effects, which can creep in without the person noticing.
Side effects & risks:
- Nausea, dizziness, headache, and orthostatic hypotension (lightheadedness on standing) are the common early effects. Usually dose-dependent and eased by taking it at night with food and going low and slow
- Impulse control disorders are the signature serious risk: compulsive gambling, compulsive spending, binge eating, hypersexuality. Driven by the drug's action on dopamine reward pathways, documented in clinical studies and carried as an explicit warning in the prescribing information. Often noticed by people around you before you notice it yourself. Tell someone close to you that you're taking it
- Mood effects. Depression, anxiety, and emotional flatness or anhedonia are reported, particularly when the dose is too high or prolactin is pushed too low. Rare cases of mania and psychosis exist
- Overshooting prolactin. Driving prolactin below the normal range is easy with this drug and is counterproductive. In men it can flatten mood and motivation, in women it specifically worsens sexual function and mood. Aim for normal, not minimal
- Valvular heart disease. Cabergoline is an ergot dopamine agonist, the class linked to fibrotic heart valve changes via 5-HT2B activation. The clear risk is in Parkinson's patients on very high cumulative doses. At the low doses used for prolactin, large reviews have not found clinically significant valve disease, but the mechanism still exists, so baseline and periodic echocardiograms are standard practice
- Pregnancy and fertility. Cabergoline can restore fertility quickly by normalizing prolactin, which matters if pregnancy is not the goal. It is generally stopped once pregnancy is confirmed unless there's a specific medical reason to continue. Not for casual use in anyone who could become pregnant
- Contraindications and interactions. Avoid with uncontrolled hypertension, existing valvular heart disease, or a history of pulmonary, pericardial, or retroperitoneal fibrosis. Don't combine with other ergot derivatives. Use caution with blood pressure medication. Antipsychotics and metoclopramide counteract it
Blood markers
Prolactin, the marker that actually guides dosing. Baseline before starting, then recheck about 4 weeks after starting or after any dose change, since the long half-life means levels take time to settle. The goal is prolactin in the normal range, not the floor, driving it below normal worsens mood and sexual function in both men and women.
Total and free testosterone, LH, baseline and on follow-up if you're using cabergoline because high prolactin was suppressing your testosterone. This is how you confirm the gonadal axis is actually recovering rather than just watching one number move.
Echocardiogram, baseline before starting, and periodically if you use it for years. Not a blood test, but it's the monitoring that matters most for an ergot dopamine agonist. Standard guidance is a repeat scan at 5 years for low weekly doses, more often above roughly 2 mg per week.
Vitamin D, baseline, especially for women. Deficiency blunts cabergoline's benefits on sexual function and mood, so correcting it first makes the drug work better. See the Vitamin D page.
For someone using a low dose to manage prolactin on a 19-nor steroid cycle, prolactin plus a testosterone panel covers the essentials, and a baseline echocardiogram is sensible if it'll be ongoing. Anyone with cardiac symptoms, uncontrolled blood pressure, or a fibrosis history should not be self-managing this at all.
Cabergoline is a prescription medication in most countries.
Made with Bullet